Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations

Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate

(2014) I S Hamadeh et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

(2014) J Picot et al.   HEALTH TECHNOLOGY ASSESSMENT

Visceral Fat and Body Composition Changes in a Female Population After RYGBP: a Two-Year Follow-Up by DXA

(2014) Alberto Bazzocchi et al.   OBESITY SURGERY

A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics

(2013) C M Blake et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Variability of Bioavailability and Intestinal Absorption Mechanisms of Metoprolol

(2013) Miki Fukao et al.   Drug Metabolism and Pharmacokinetics

Site dependent intestinal absorption of darunavir and its interaction with ketoconazole

(2013) Jef Stappaerts et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The Influence of Bypass Procedures and Other Anatomical Changes in the Gastrointestinal Tract on the Oral Bioavailability of Drugs

(2013) Julie De Smet et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

(2013) C. Dirksen et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The Effect of Bariatric Surgery on Intestinal Absorption and Transit Time

(2013) Kirstin A. Carswell et al.   OBESITY SURGERY

Effect of gastric bypass surgery on azithromycin oral bioavailability

(2012) R. S. Padwal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution

(2012) Adam S. Darwich et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Accelerated Gastric Emptying but No Carbohydrate Malabsorption 1 Year After Gastric Bypass Surgery (GBP)

(2012) Gary Wang et al.   OBESITY SURGERY

Improvement in Cardiovascular Indices After Roux-en-Y Gastric Bypass or Sleeve Gastrectomy for Morbid Obesity

(2012) Alexander Kokkinos et al.   OBESITY SURGERY

Improved Levothyroxine Pharmacokinetics After Bariatric Surgery

(2012) Margarita Gkotsina et al.   THYROID

Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science

(2011) Malcolm Rowland et al.   Annual Review of Pharmacology and Toxicology

Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients

(2011) Cyrus Ghobadi et al.   CLINICAL PHARMACOKINETICS

Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin

(2011) R. S. Padwal et al.   DIABETES CARE

Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A

(2009) Sandrine Turpault et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients

(2009) I B Skottheim et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A systematic review of drug absorption following bariatric surgery and its theoretical implications

(2009) R. Padwal et al.   Obesity Reviews